{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:57:54Z","timestamp":1786121874883,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005978","name":"Ministere de la Sante et des Solidarites","doi-asserted-by":"publisher","award":["PHRC-I-15-067"],"award-info":[{"award-number":["PHRC-I-15-067"]}],"id":[{"id":"10.13039\/501100005978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.06.045","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:16:57Z","timestamp":1784330217000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enoxaparin for the treatment of placenta-derived fetal growth restriction (GROWTH): an open-label multicenter randomized trial"],"prefix":"10.1016","author":[{"given":"Tiphaine","family":"Raia-Barjat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-8668","authenticated-orcid":false,"given":"Silvy","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Gaucherand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Huissoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Gallot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Merviel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Zufferey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Presles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Chauleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.045_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.06.021","article-title":"Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians","volume":"193","author":"Vayssi\u00e8re","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jtha.2026.06.045_bib2","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/AOG.0000000000003070","article-title":"ACOG practice bulletin no. 204: fetal growth restriction","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000429658.85846.f9","article-title":"ACOG practice bulletin no. 134: fetal growth restriction","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib5","first-page":"490","article-title":"Intrauterine growth restriction","volume":"99","author":"Resnik","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajog.2006.09.017","article-title":"Risk factors for antepartum and intrapartum stillbirth: a population-based study","volume":"196","author":"Getahun","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00003081-200606000-00008","article-title":"Perinatal outcome and later implications of intrauterine growth restriction","volume":"49","author":"Pallotto","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","article-title":"Adult consequences of fetal growth restriction","volume":"49","author":"Barker","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib9","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S1701-2163(16)34300-6","article-title":"Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis","volume":"31","author":"Bujold","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jtha.2026.06.045_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semperi.2008.04.010","article-title":"Fetal growth restriction","volume":"32","author":"Miller","year":"2008","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jtha.2026.06.045_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1471-0528.1985.tb01045.x","article-title":"Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation","volume":"92","author":"Giles","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0002-9378(89)90783-7","article-title":"Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep","volume":"161","author":"Morrow","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"key":"10.1016\/j.jtha.2026.06.045_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00003081-199712000-00008","article-title":"Placental pathology of fetal growth restriction","volume":"40","author":"Salafia","year":"1997","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib17","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1210\/jc.2006-2774","article-title":"Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction","volume":"92","author":"Stepan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2026.06.045_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1055\/s-0038-1649882","article-title":"Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia","volume":"74","author":"Janes","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.045_bib19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","article-title":"Etiology and pathogenesis of preeclampsia: current concepts","volume":"179","author":"Dekker","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s43032-021-00678-0","article-title":"Low molecular weight heparins (LMWH) and implications along pregnancy: a focus on the placenta","volume":"29","author":"Zullino","year":"2022","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jtha.2026.06.045_bib21","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ultrasmedbio.2006.05.030","article-title":"Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension","volume":"32","author":"Torricelli","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jtha.2026.06.045_bib23","first-page":"793","article-title":"[Effect of heparin on fetal growth restriction]","volume":"39","author":"Yu","year":"2004","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.jtha.2026.06.045_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2018.08.006","article-title":"Tinzaparin for the treatment of foetal growth retardation: an open-labelled randomized clinical trial","volume":"170","author":"Hansen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.045_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijgo.15098","article-title":"Effect of low-molecular-weight heparin on placenta-mediated fetal growth restriction in a tertiary referral hospital: a 7-year retrospective cohort study","volume":"165","author":"Xu","year":"2024","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jtha.2026.06.045_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2023.2183748","article-title":"Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study","volume":"36","author":"Borella","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jtha.2026.06.045_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jgyn.2015.01.006","article-title":"Courbe d\u2019estimation de poids f\u0153tal 2014 par le Coll\u00e8ge fran\u00e7ais d'\u00e9chographie f\u0153tale (CFEF) [Chart for estimation of fetal weight 2014 by the French College of Fetal Sonography (CFEF)]","volume":"45","author":"Massoud","year":"2016","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jtha.2026.06.045_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.gyobfe.2003.08.008","article-title":"Pr\u00e9vention des risques thrombotiques maternels et placentaires (mars 2003). Texte des recommandations (version courte) [Thrombophilia and pregnancy. Prevention of thrombotic maternal and placental risks (March 2003)]","volume":"31","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jtha.2026.06.045_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/uog.20282","article-title":"Prenatal identification of small-for-gestational age and risk of neonatal morbidity and stillbirth","volume":"55","author":"Nohuz","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.045_bib32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jth.14576","article-title":"Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: a systematic review and a proposal from the ISTH SSC","volume":"17","author":"Tardy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.045_bib33","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"2013","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2026.06.045_bib34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1148\/radiology.213.3.r99dc08681","article-title":"Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries","volume":"213","author":"Fong","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.jtha.2026.06.045_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1538-7836.2011.04407.x","article-title":"Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial","volume":"9","author":"Kingdom","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.045_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/14767050903443459","article-title":"Heparin for patients with growth restricted fetus: a prospective randomized controlled trial","volume":"23","author":"Yu","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jtha.2026.06.045_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/aogs.13730","article-title":"Heparin therapy in placental insufficiency: systematic review and meta-analysis","volume":"99","author":"Mazarico","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2026.06.045_bib38","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.045_bib39","doi-asserted-by":"crossref","first-page":"296.e1","DOI":"10.1016\/j.ajog.2017.01.014","article-title":"Enoxaparin for Prevention of Preeclampsia and Intrauterine Growth Restriction Trial Investigator Group. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial","volume":"216","author":"Groom","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib40","doi-asserted-by":"crossref","first-page":"552.e1","DOI":"10.1016\/j.ajog.2024.10.055","article-title":"Treatment of early-onset fetal growth restriction with low molecular weight heparin does not prolong gestation: a randomized clinical trial","volume":"232","author":"Gonz\u00e1lez","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib41","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41390-025-04347-9","article-title":"Neonatal morbidity in early-onset fetal growth restriction with and without anticoagulant therapy","volume":"99","author":"Gonz\u00e1lez","year":"2026","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jtha.2026.06.045_bib42","doi-asserted-by":"crossref","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.06.045_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020501","article-title":"Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP)","volume":"8","author":"Mazarico","year":"2018","journal-title":"BMJ Open"},{"issue":"suppl 3","key":"10.1016\/j.jtha.2026.06.045_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/1471-0528.17613","article-title":"The great obstetrical syndromes and the placenta","volume":"130","author":"Hoffman","year":"2023","journal-title":"BJOG"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:01:50Z","timestamp":1786086110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S1538783626004320"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.045","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enoxaparin for the treatment of placenta-derived fetal growth restriction (GROWTH): an open-label multicenter randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}